BiotechTube
Home/Arietis Pharma/Michael LaFleur, Ph.D., MBA
ML

Michael LaFleur, Ph.D., MBA

Chief Executive Officer

Arietis Pharma

Therapeutic Areas

Infectious DiseaseAntimicrobial Resistance

Arietis Pharma Pipeline

DrugIndicationPhase
ClpP Activator PlatformComplicated drug-resistant Gram-positive bacterial infections (e.g., prosthetic joint infections, osteomyelitis, endocarditis)Pre-clinical

Leadership Team at Arietis Pharma

KL
Kim Lewis, Ph.D.
Founder & Chairman of the Board
View full Arietis Pharma profile